Vimarsana
Biggest News Aggregation in the World

Page 3 - Inhalation Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inhalation Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inhalation Solution Today - Breaking & Trending Today

Lupin buys two inhalation brands from Sunovion Pharma for $75 M - Vimarsana News

Lupin buys two inhalation brands from Sunovion Pharma for $75 M

To expand Lupin's portfolio of inhalation products in the US

United Therapeutics Says Prevails In Dry Powder Inhaler Patent Litigation - Vimarsana News

United Therapeutics Says Prevails In Dry Powder Inhaler Patent Litigation

(RTTNews) - United Therapeutics Corp. (UTHR) said that it has prevailed in dry powder inhaler patent litigation with Liquidia Technologies. Unite...

United Therapeutics Corporation Reports Second Quarter 2022 Financial Results - Vimarsana News

United Therapeutics Corporation Reports Second Quarter 2022 Financial Results

03.08.2022 - United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended June 30, 2022. Total revenues in the second quarter of 2022 grew 5% year-over-year to $466.9 million, compared ...

MannKind's Technosphere® Inhalation Platform Utilized in - Vimarsana News

MannKind's Technosphere® Inhalation Platform Utilized in

Tyvaso DPI represents the second FDA-approved product utilizing MannKind’s Technosphere® inhalation technologyFirst approval of a dry powder inhaled...

Polyphor and EnBiotix Announce Dosing of First Patient in a First-in-Human Clinical Trial of Inhaled Murepavadin - Vimarsana News

Polyphor and EnBiotix Announce Dosing of First Patient in a First-in-Human Clinical Trial of Inhaled Murepavadin

Press release content from Accesswire. The AP news staff was not involved in its creation.

Source: apnews.com